Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Viewpoint

Vol. 148 No. 2526 (2018)

Look before you SPRINT: look at the data and look at the consequences

  • Alain Nordmann
  • Michael Fernandes
  • Marcel GM Olde Rikkert
DOI
https://doi.org/10.4414/smw.2018.14629
Cite this as:
Swiss Med Wkly. 2018;148:w14629
Published
01.07.2018

References

  1. Whelton PK, Carey RM, Aronow WS, Casey DE, Jr, Collins KJ, Dennison Himmelfarb C, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127–248. [doi:.].https://doi.org/10.1016/j.jacc.2017.11.006
  2. Wright JT, Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al., SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16. [doi:.].https://doi.org/10.1056/NEJMoa1511939
  3. Kjeldsen SE, Lund-Johansen P, Nilsson PM, Mancia G. Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial: Implications for Entry and Achieved Blood Pressure Values Compared With Other Trials. Hypertension. 2016;67(5):808–12. [doi:.].https://doi.org/10.1161/HYPERTENSIONAHA.116.07257
  4. Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, et al., STOPIT-2 Study Group. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA. 2010;303(12):1180–7. [doi:.].https://doi.org/10.1001/jama.2010.310
  5. Crawford C. AAFP decides to not endorse AHA/ACC hypertension guideline. Academy continues to endorse JNC 8 guideline. Announcement, American Academy of Family Physicians, December 12, 2017. https://www.aafp.org/news/health-of-the-public/20171212notendorseaha-accgdlne.html
  6. Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, et al. Expertise: No longer a sine qua non for guideline authors? Hypertension. 2017;70(2):235–7. [doi:.].https://doi.org/10.1161/HYPERTENSIONAHA.117.09470
  7. Ioannidis JPA. Diagnosis and Treatment of Hypertension in the 2017 ACC/AHA Guidelines and in the Real World. JAMA. 2018;319(2):115–6. [doi:.].https://doi.org/10.1001/jama.2017.19672
  8. Sexton DJ, Canney M, O’Connell MDL, Moore P, Little MA, O’Seaghdha CM, et al. Injurious falls and syncope in older community-dwelling adults meeting inclusion criteria for SPRINT. JAMA Intern Med. 2017;177(9):1385–7. [doi:.].https://doi.org/10.1001/jamainternmed.2017.2924
  9. van der Wardt V, Harrison JK, Welsh T, Conroy S, Gladman J. Withdrawal of antihypertensive medication: a systematic review. J Hypertens. 2017;35(9):1742–9. [doi:.].https://doi.org/10.1097/HJH.0000000000001405
  10. Brunström M, Carlberg B. Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis. JAMA Intern Med. 2018;178(1):28–36. [doi:.].https://doi.org/10.1001/jamainternmed.2017.6015
  11. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148(4):295–309. [doi:.].https://doi.org/10.7326/0003-4819-148-4-200802190-00008